What is the life expectancy of someone with Ledderhoses Disease / Plantar Fibromatosis?

Ledderhose disease, also known as plantar fibromatosis, does not reduce life expectancy and is not a life-limiting condition. It is a benign, non-malignant condition characterized by the development of nodules in the plantar fascia, and most patients live a normal lifespan with appropriate symptom management.

What is the long-term prognosis for Ledderhose disease?

The prognosis for Ledderhose disease is excellent regarding survival, as the condition is benign and does not metastasize or shorten life expectancy. However, the condition is chronic and progressive in nature, meaning that while it poses no threat to longevity, it can significantly impact an individual's daily comfort and mobility. The 95 members of the Ledderhose disease community on DiseaseMaps.org frequently share experiences regarding the fluctuating nature of the nodules, which can vary in size and pain levels over many years. Because the condition is not fatal, clinical focus is directed entirely toward preserving function and managing pain.

Does Ledderhose disease impact quality of life?

While Ledderhose disease does not affect how long you live, it can certainly affect how you live. The formation of fibromas on the sole of the foot can make walking, standing for long periods, or wearing certain types of footwear difficult. Factors that influence the severity of this impact include:

• Nodule size and location: Larger or more centrally located nodules are more likely to cause discomfort during weight-bearing activities.


• Comorbidities: Patients who also have Dupuytren’s contracture (a similar condition affecting the hands) or Peyronie’s disease may experience a more systemic fibromatosis profile.


• Treatment adherence: Early intervention with non-surgical therapies can often delay the need for more invasive procedures.


• Lifestyle adjustments: The use of custom orthotics or physical therapy can significantly mitigate pain and maintain mobility.

How have treatment outcomes for plantar fibromatosis improved?

Over the past few decades, the management of Ledderhose disease has shifted from aggressive surgical intervention—which often resulted in high recurrence rates—toward more conservative, patient-centered approaches. Modern clinicians now favor minimally invasive options such as collagenase injections, corticosteroid injections, and radiotherapy, which help manage symptoms without the long recovery times associated with surgery. These advancements mean that patients with Ledderhose disease can now maintain active lifestyles for much longer than was previously possible, prioritizing the preservation of foot architecture and function.

Why is regular medical follow-up important?

Even though Ledderhose disease is benign, regular monitoring by a podiatrist or orthopedic specialist is essential to track the progression of the fibromas. Routine check-ups allow for the early detection of changes that might warrant a change in therapy, such as an increase in pain or a rapid change in the size of the nodules. Consistent follow-up ensures that you are accessing the latest evidence-based treatments and allows your medical team to address the psychosocial aspects of living with a chronic, visible, and sometimes painful condition.

Next steps

• Consult a podiatrist or orthopedic foot and ankle specialist to establish a baseline for your Ledderhose disease.


• Consider physical therapy to maintain flexibility and strength in the foot and ankle.


• Join the Ledderhose disease community on DiseaseMaps.org to connect with others who share similar experiences and coping strategies.


• Keep a symptom journal to track how different footwear or activities affect your pain levels, which can be useful during clinical consultations.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Plantar fibromatosis.


• Orphanet: Ledderhose disease.


• OMIM (Online Mendelian Inheritance in Man): Fibromatosis, Plantar.


• DiseaseMaps.org: Community-reported outcomes for Ledderhose disease/Plantar fibromatosis.